Titan制药

TTNP NASDAQ
1.340
-0.070
-4.96%
盘后: 1.340 0 0.00% 17:05 05/24 EDT
开盘
1.410
昨收
1.410
最高
1.440
最低
1.310
成交量
23.45万
成交均量(3M)
80.10万
52周最高
6.90
52周最低
1.032
换手率
1.74%
市值
1,810.31万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供Titan制药 TTNP股票价格,Titan制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.
展开 >

最近浏览

名称
价格
涨跌幅